These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28905438)

  • 21. Clinical Styles and Practice Policies: Influence on Communication with Patients Regarding Worrisome Prescription Drug Monitoring Program Data.
    Hildebran C; Leichtling G; Irvine JM; Cohen DJ; Hallvik SE; Deyo RA
    Pain Med; 2016 Nov; 17(11):2061-2066. PubMed ID: 27009292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Who uses a prescription drug monitoring program and how? Insights from a statewide survey of Oregon clinicians.
    Irvine JM; Hallvik SE; Hildebran C; Marino M; Beran T; Deyo RA
    J Pain; 2014 Jul; 15(7):747-55. PubMed ID: 24787089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effectiveness of prescription drug monitoring programs at reducing opioid-related harms and consequences: a systematic review.
    Rhodes E; Wilson M; Robinson A; Hayden JA; Asbridge M
    BMC Health Serv Res; 2019 Nov; 19(1):784. PubMed ID: 31675963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prescription drug monitoring programs, nonmedical use of prescription drugs, and heroin use: Evidence from the National Survey of Drug Use and Health.
    Ali MM; Dowd WN; Classen T; Mutter R; Novak SP
    Addict Behav; 2017 Jun; 69():65-77. PubMed ID: 28152391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prescription Drug Monitoring Programs Are Associated With Sustained Reductions In Opioid Prescribing By Physicians.
    Bao Y; Pan Y; Taylor A; Radakrishnan S; Luo F; Pincus HA; Schackman BR
    Health Aff (Millwood); 2016 Jun; 35(6):1045-51. PubMed ID: 27269021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluating the impact of prescription drug monitoring program implementation: a scoping review.
    Finley EP; Garcia A; Rosen K; McGeary D; Pugh MJ; Potter JS
    BMC Health Serv Res; 2017 Jun; 17(1):420. PubMed ID: 28633638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Impact of Prescription Drug Monitoring Programs and Prescribing Guidelines on Emergency Department Opioid Prescribing: A Multi-Center Survey.
    Pomerleau AC; Nelson LS; Hoppe JA; Salzman M; Weiss PS; Perrone J
    Pain Med; 2017 May; 18(5):889-897. PubMed ID: 26995800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variations in prescription drug monitoring program use by prescriber specialty.
    Sun BC; Lupulescu-Mann N; Charlesworth CJ; Kim H; Hartung DM; Deyo RA; John McConnell K
    J Subst Abuse Treat; 2018 Nov; 94():35-40. PubMed ID: 30243415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Effect of a Statewide Mandatory Prescription Drug Monitoring Program on Opioid Prescribing by Emergency Medicine Providers Across 15 Hospitals in a Single Health System.
    Suffoletto B; Lynch M; Pacella CB; Yealy DM; Callaway CW
    J Pain; 2018 Apr; 19(4):430-438. PubMed ID: 29241835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systematic Literature Review of Prescription Drug Monitoring Programs.
    Ponnapalli A; Grando A; Murcko A; Wertheim P
    AMIA Annu Symp Proc; 2018; 2018():1478-1487. PubMed ID: 30815193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical decision making involving prescription drug monitoring programs: A factorial, vignette-based study among student pharmacists.
    Tata V; Varisco TJ; Du N; Nguyen J; Haghparast P; Thornton JD
    J Am Pharm Assoc (2003); 2021; 61(3):316-324. PubMed ID: 33579594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. U.S. Opioid Epidemic: Impact on Public Health and Review of Prescription Drug Monitoring Programs (PDMPs).
    Boté SH
    Online J Public Health Inform; 2019; 11(2):e18. PubMed ID: 31632612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Barriers, solutions, and effect of using pharmacogenomics data to support opioid prescribing.
    Bright D; Petry N; Roath E; Reckow E; Chavour S
    J Manag Care Spec Pharm; 2020 Dec; 26(12):1597-1602. PubMed ID: 33252002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "Nobody Knows How You're Supposed to Interpret it:" End-user Perspectives on Prescription Drug Monitoring Program in Massachusetts.
    Hong M; Seymour S; Stopka TJ; Bandanza L; Crocker E; Morgan A; Beletsky L
    J Addict Med; 2022 May-Jun 01; 16(3):e171-e176. PubMed ID: 34417413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resident Access to the St. Louis County Prescription Drug Monitoring Program: Why PDMPs Matter and How to Gain Access.
    Lange J; Gaddis G; Varner E; Schmidt S; Cohen R; Schwarz E
    Mo Med; 2018; 115(6):487-493. PubMed ID: 30643325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prescription drug monitoring programs in the US: A systematic literature review on its strength and weakness.
    Alogaili F; Abdul Ghani N; Ahmad Kharman Shah N
    J Infect Public Health; 2020 Oct; 13(10):1456-1461. PubMed ID: 32694082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prescription drug monitoring programs: Assessing the association between "best practices" and opioid use in Medicare.
    Moyo P; Simoni-Wastila L; Griffin BA; Harrington D; Alexander GC; Palumbo F; Onukwugha E
    Health Serv Res; 2019 Oct; 54(5):1045-1054. PubMed ID: 31372990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How, why, and for whom do emergency medicine providers use prescription drug monitoring programs?
    Smith RJ; Kilaru AS; Perrone J; Paciotti B; Barg FK; Gadsden SM; Meisel ZF
    Pain Med; 2015 Jun; 16(6):1122-31. PubMed ID: 25688454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of state prescription drug monitoring programs: a state-by-state survey.
    Manasco AT; Griggs C; Leeds R; Langlois BK; Breaud AH; Mitchell PM; Weiner SG
    Pharmacoepidemiol Drug Saf; 2016 Jul; 25(7):847-51. PubMed ID: 27061342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.